Get notified when NUWE files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsNuwellis adds warrant repricing and reverse split condition to offering
Filed June 4, 2026 · Compared to S-1/A May 29, 2026 · ~1 min read
Key Changes
-
high
New warrant repricing transaction reduces exercise price of up to 3.28M warrants to the public offering price, subject to stockholder approval.
Offering verify on EDGAR → -
high
Common warrants now require both stockholder approval and a reverse stock split before they can be exercised, delaying potential dilution.
Offering verify on EDGAR → -
medium
Risk factors updated to reflect the added reverse split condition, warning warrants may have no value if conditions aren't met.
Risk Factors verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (LSAK 10-K) is open in full — no account needed.
Partner
Trade NUWE commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 30, 2026 · How we verify